Share This

Hot News @ 禁言

 < Previous page   
Related Keyword:連花清瘟 , 王思聰
Related Concept:質疑連花清瘟膠囊 , 王思聰微博禁言
 
【連花清瘟】以嶺藥業否認「連花清瘟」研發過程僅15日、正進行新冠雙盲研究王思聰醫藥平台狙擊、股價一周跌逾25 ... @ 2022-04-21T00:
內地、香港最新一輪新冠疫情期間,以嶺醫藥(深:002603)旗下中成藥「連花清瘟膠囊」大賣,甚至成為內地支援香港的物資,但最新在內地陷成效風波。
Keyword:連花清瘟 王思聰
Concept:質疑連花清瘟膠囊 , 王思聰微博禁言
 < Previous page   

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.